The global Orodispersible Tablets Market is estimated to be valued at US$ 9.29 Bn in 2022 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Orodispersible tablets, also known as quick-dissolve or melt-in-mouth tablets, are designed to dissolve rapidly on the tongue without the need for water. They provide ease of administration, especially for patients with dysphagia or difficulty swallowing conventional tablets or capsules. Orodispersible tablets are gaining popularity among patients, as they offer convenient drug delivery and are suitable for people of all ages, including pediatric and geriatric patients. These tablets are widely used for the treatment of various medical conditions such as allergies, pain management, cardiovascular diseases, and gastrointestinal disorders.
Market Dynamics:
The market dynamics of the global Orodispersible Tablets Market are driven by several factors. One of the key drivers is the increasing patient preference for a convenient drug delivery system. Orodispersible tablets eliminate the need for swallowing large conventional tablets, making them more patient-friendly. Additionally, these tablets have enhanced bioavailability and faster onset of action, further contributing to their growing demand.
Furthermore, the rising prevalence of chronic diseases, such as cardiovascular diseases and respiratory disorders, is fueling the demand for Orodispersible tablets. These tablets provide an effective and efficient mode of drug administration for chronic disease management.
Segment Analysis:
The global Orodispersible Tablets Market can be segmented based on disease indication, distribution channel, and region. On the basis of disease indication, the market is categorized into central nervous system (CNS) disorders, gastrointestinal disorders, cardiovascular diseases, respiratory disorders, and others. The CNS disorders segment is anticipated to dominate the market, owing to the increasing prevalence of neurological disorders, such as Alzheimer’s disease and Parkinson’s disease, among the global population.
PEST Analysis:
Political: There are various regulations and policies implemented by governments across different regions to ensure the safety and efficacy of pharmaceutical products, which impact the Orodispersible Tablets Market.
Economic: The growing healthcare expenditure and increasing disposable income of consumers are driving the demand for Orodispersible tablets.
Social: The increasing awareness about convenient drug delivery systems and the preference for patient-friendly medication are driving the market growth.
Technological: Advancements in pharmaceutical technology, such as improved manufacturing processes and innovative formulations, are contributing to the development of Orodispersible tablets.
Key Takeaways:
– The Global Orodispersible Tablets Market Growth is expected to witness high, exhibiting a CAGR of 9.3% over the forecast period, due to increasing patient preference for a convenient drug delivery system.
– North America is expected to dominate the market, owing to well-established healthcare infrastructure, higher healthcare expenditure, and increasing adoption of advanced pharmaceutical products in the region.
– Key players operating in the global Orodispersible Tablets Market are AstraZeneca PLC, GlaxoSmithKline PLC, Novartis International AG, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Pfizer Inc., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Inc., Torrent Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Eisai Co., Ltd., and Takeda Pharmaceutical Company Limited.
In conclusion, the global Orodispersible Tablets Market is expected to experience significant growth in the coming years, driven by the increasing preference for convenient drug delivery systems and the rising prevalence of chronic diseases. The market offers lucrative opportunities for key players to introduce innovative products and expand their market presence.
